Vol 58, No 6 (2024)
Invited Editorial
Published online: 2024-12-05
Polyneuropathy and levodopa therapy in Parkinson’s Disease: an evolving clinical challenge
123
Abstract
Not available
References
- Dulski J, Uitti RJ, Ross OA, et al. Genetic architecture of Parkinson's disease subtypes - Review of the literature. Front Aging Neurosci. 2022; 14: 1023574.
- Duda K, Chmiela T, Cieśla-Fuławka A, et al. Are 5-2-1 Delphi criteria and MANAGE-PD useful screening tools for general neurologists for qualification to device-aided therapies in advanced Parkinson's Disease? Neurol Neurochir Pol. 2024; 58(4): 422–428.
- Rusinek J, Porębska K, Sawczyńska K, et al. Visual disturbances in patients with Parkinson's Disease treated with oral medications or deep brain stimulation. Neurol Neurochir Pol. 2023; 57(4): 392–396.
- Nowak J, Antoniak A, Kopczyński M, et al. Validation of Polish version of Gastrointestinal Dysfunction Scale for Parkinson’s Disease. Neurologia i Neurochirurgia Polska. 2024; 58(3): 338–346.
- Malkiewicz JJ, Siuda J. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy. Neurol Neurochir Pol. 2024; 58(2): 193–202.
- Ferreira JJ, Katzenschlager R, Bloem BR, et al. Summary of the recommendations of the
EFNS /MDS ‐ES review on therapeutic management ofP arkinson's disease. European Journal of Neurology. 2012; 20(1): 5–15. - Espay A, Stocchi F, Pahwa R, et al. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial. The Lancet Neurology. 2024; 23(5): 465–476.
- Ahlskog J. Levodopa, homocysteine and Parkinson's disease: What's the problem? Parkinsonism & Related Disorders. 2023; 109: 105357.
- Déry C, Buchmann C, Labrecque G, et al. Oral Levodopa Therapy, Vitamin B6 and Peripheral Neuropathy: A Cross-Sectional Observational Study. Mov Disord Clin Pract. 2024 [Epub ahead of print].
- Piekarski R, Roszmann A, Dulski J, et al. Acute/subacutae demyelinating polyneuropathy in Parkinson's Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report. Neurol Neurochir Pol. 2023; 57(2): 169–176.
- Piekarski R, Roszmann A, Dulski J, et al. Response to 'Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out'. Neurol Neurochir Pol. 2023; 57(4): 403–404.
- Szadejko K, Dziewiatowski K, Szabat K, et al. Polyneuropathy in levodopa-treated Parkinson's patients. J Neurol Sci. 2016; 371: 36–41.
- Havránková P. Acute polyneuropathy: a serious complication of levodopa/ /carbidopa intestinal gel treatment for Parkinson’s Disease. Neurol Neurochir Pol 2024;58:1–7. https://doi org/10 5603/pjnns. ; 100132.
- Dulski J, Ross O, Wszolek Z. Genetics of Parkinson’s Disease: state-of-the-art and role in clinical settings. Neurologia i Neurochirurgia Polska. 2024; 58(1): 38–46.
- Białecka M, Kurzawski M, Roszmann A, et al. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease. Pharmacogenet Genomics. 2012; 22(10): 716–724.
- Ivanova K, Žukovs D, Možeitoviča E, et al. Prevalence of polyneuropathies among systemic sclerosis patients and impact on health-related quality of life. Neurologia i Neurochirurgia Polska. 2023; 57(2): 206–211.
- Radziwon J, Sławek J. Ultrasonographically measured atrophy of vagus nerve in Parkinson’s Disease: clinical and pathogenetic insights plus systematic review and meta-analysis. Neurologia i Neurochirurgia Polska. 2024; 58(5): 471–483.
- Finsterer J. Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out. Neurologia i Neurochirurgia Polska. 2023; 57(4): 401–402.
- Martino JV, Van Limbergen J, Cahill LE. The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation. Front Pediatr. 2017; 5: 96.
